Blog

Human-derived models enable NAMs integration in drug discovery workflows, improving translational safety assessment while reducing reliance on animal testing. Read full blog at BioIVT.

Limited predictivity in some animal models has driven adoption of human‑based systems, with primary lung cells central to translational in vitro research. Read the full blog at BioIVT. [...]

Access to human biospecimens for EU preclinical research is governed by regulatory frameworks protecting donors, data, and ethics. Read the complete blog at BioIVT's website.

Preclinical safety assessment has traditionally relied on animal studies to identify potential toxicities and guide first‑in‑human dosing decisions. Read the full blog at BioIVT.

Human biospecimens are essential for preclinical research, but their value goes beyond their biological origin. Sample handling, storage, and transport impacts on their quality and, therefore, on the reliability [...]

Human biospecimens are a critical input for preclinical research, but their scientific value is highly dependent on how they are handled throughout their lifecycle. Variability introduced during collection, processing, [...]